- TOP
- NEWS
- New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good
Warning: foreach() argument must be of type array|object, false given in /home/jollygood25s/jollygoodinc.com/public_html/wp-content/themes/jollygood-en/single-news.php on line 35
Warning: Undefined variable $term_name in /home/jollygood25s/jollygoodinc.com/public_html/wp-content/themes/jollygood-en/single-news.php on line 42
Warning: Undefined variable $term_id in /home/jollygood25s/jollygoodinc.com/public_html/wp-content/themes/jollygood-en/single-news.php on line 44
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good
Agreement Worth Potentially 5 Billion Yen for the VR Healthcare Market
Jolly Good Inc. and Otsuka Pharmaceutical Co., Ltd. (Chiyoda-ku, Tokyo; President and Representative Director: Makoto Inoue) have signed an agreement for exclusive product joint development and sales in Japan for a social skill training VR (“SST VR”) business. If including a 300 millon yen upfront payment from Otsuka Pharmaceutical to Jolly Good, as well as development cost reimbursement and royalties, the deal is worth 5 billion yen.
